Light Seminars
July 12, 2016
L4H Seminar REGINE CHOE 'Can Diffuse Optical and Correlation Tomography Predict Treatment Efficacy for Bone Injury and Cancer?'
L4H Seminar REGINE CHOE 'Can Diffuse Optical and Correlation Tomography Predict Treatment Efficacy for Bone Injury and Cancer?'
REGINE CHOE
University of Rochester Medical Center
Tuesday, July 12, 2016, 12:00. Seminar Room
REGINE CHOE
University of Rochester Medical Center
REGINE CHOE
University of Rochester Medical Center
Diffuse optical and correlation tomography have a great potential to monitor and predict the efficacy of treatments that affect vascular parameters, since they provide non-invasive measurements of oxygenated and deoxygenated hemoglobin, and blood flow. In addition, the use of non-ionizing radiation and technologically simple, fast, inexpensive instrumentation makes diffuse optics attractive for translational research.
In this presentation, clinical and preclinical research tools and approaches to test the capabilities of diffuse optics in early prediction of therapeutic efficacy will be introduced. For bone graft monitoring, temporal and spatial blood flow distributions from murine segmental defect model will be presented for different graft types with varying healing capacity: autografts, allografts, and allografts with tissue-engineered periosteum. For breast cancer monitoring, high correlation between temporal blood flow changes and the treatment efficacy assessed by tumor size changes in a murine breast cancer model will be shown. In addition, the potential of a multi-parametric approach based on clinical diffuse optical measurements to predict neoadjuvant chemotherapy efficacy will be demonstrated.
Diffuse optical and correlation tomography have a great potential to monitor and predict the efficacy of treatments that affect vascular parameters, since they provide non-invasive measurements of oxygenated and deoxygenated hemoglobin, and blood flow. In addition, the use of non-ionizing radiation and technologically simple, fast, inexpensive instrumentation makes diffuse optics attractive for translational research.
In this presentation, clinical and preclinical research tools and approaches to test the capabilities of diffuse optics in early prediction of therapeutic efficacy will be introduced. For bone graft monitoring, temporal and spatial blood flow distributions from murine segmental defect model will be presented for different graft types with varying healing capacity: autografts, allografts, and allografts with tissue-engineered periosteum. For breast cancer monitoring, high correlation between temporal blood flow changes and the treatment efficacy assessed by tumor size changes in a murine breast cancer model will be shown. In addition, the potential of a multi-parametric approach based on clinical diffuse optical measurements to predict neoadjuvant chemotherapy efficacy will be demonstrated.
Tuesday, July 12, 2016, 12:00. Seminar Room
Hosted by Prof. Turgut Durduran
In this presentation, clinical and preclinical research tools and approaches to test the capabilities of diffuse optics in early prediction of therapeutic efficacy will be introduced. For bone graft monitoring, temporal and spatial blood flow distributions from murine segmental defect model will be presented for different graft types with varying healing capacity: autografts, allografts, and allografts with tissue-engineered periosteum. For breast cancer monitoring, high correlation between temporal blood flow changes and the treatment efficacy assessed by tumor size changes in a murine breast cancer model will be shown. In addition, the potential of a multi-parametric approach based on clinical diffuse optical measurements to predict neoadjuvant chemotherapy efficacy will be demonstrated.
Diffuse optical and correlation tomography have a great potential to monitor and predict the efficacy of treatments that affect vascular parameters, since they provide non-invasive measurements of oxygenated and deoxygenated hemoglobin, and blood flow. In addition, the use of non-ionizing radiation and technologically simple, fast, inexpensive instrumentation makes diffuse optics attractive for translational research.
In this presentation, clinical and preclinical research tools and approaches to test the capabilities of diffuse optics in early prediction of therapeutic efficacy will be introduced. For bone graft monitoring, temporal and spatial blood flow distributions from murine segmental defect model will be presented for different graft types with varying healing capacity: autografts, allografts, and allografts with tissue-engineered periosteum. For breast cancer monitoring, high correlation between temporal blood flow changes and the treatment efficacy assessed by tumor size changes in a murine breast cancer model will be shown. In addition, the potential of a multi-parametric approach based on clinical diffuse optical measurements to predict neoadjuvant chemotherapy efficacy will be demonstrated.
Tuesday, July 12, 2016, 12:00. Seminar Room
Hosted by Prof. Turgut Durduran
Light Seminars
July 12, 2016
L4H Seminar REGINE CHOE 'Can Diffuse Optical and Correlation Tomography Predict Treatment Efficacy for Bone Injury and Cancer?'
L4H Seminar REGINE CHOE 'Can Diffuse Optical and Correlation Tomography Predict Treatment Efficacy for Bone Injury and Cancer?'
REGINE CHOE
University of Rochester Medical Center
Tuesday, July 12, 2016, 12:00. Seminar Room
REGINE CHOE
University of Rochester Medical Center
REGINE CHOE
University of Rochester Medical Center
Diffuse optical and correlation tomography have a great potential to monitor and predict the efficacy of treatments that affect vascular parameters, since they provide non-invasive measurements of oxygenated and deoxygenated hemoglobin, and blood flow. In addition, the use of non-ionizing radiation and technologically simple, fast, inexpensive instrumentation makes diffuse optics attractive for translational research.
In this presentation, clinical and preclinical research tools and approaches to test the capabilities of diffuse optics in early prediction of therapeutic efficacy will be introduced. For bone graft monitoring, temporal and spatial blood flow distributions from murine segmental defect model will be presented for different graft types with varying healing capacity: autografts, allografts, and allografts with tissue-engineered periosteum. For breast cancer monitoring, high correlation between temporal blood flow changes and the treatment efficacy assessed by tumor size changes in a murine breast cancer model will be shown. In addition, the potential of a multi-parametric approach based on clinical diffuse optical measurements to predict neoadjuvant chemotherapy efficacy will be demonstrated.
Diffuse optical and correlation tomography have a great potential to monitor and predict the efficacy of treatments that affect vascular parameters, since they provide non-invasive measurements of oxygenated and deoxygenated hemoglobin, and blood flow. In addition, the use of non-ionizing radiation and technologically simple, fast, inexpensive instrumentation makes diffuse optics attractive for translational research.
In this presentation, clinical and preclinical research tools and approaches to test the capabilities of diffuse optics in early prediction of therapeutic efficacy will be introduced. For bone graft monitoring, temporal and spatial blood flow distributions from murine segmental defect model will be presented for different graft types with varying healing capacity: autografts, allografts, and allografts with tissue-engineered periosteum. For breast cancer monitoring, high correlation between temporal blood flow changes and the treatment efficacy assessed by tumor size changes in a murine breast cancer model will be shown. In addition, the potential of a multi-parametric approach based on clinical diffuse optical measurements to predict neoadjuvant chemotherapy efficacy will be demonstrated.
Tuesday, July 12, 2016, 12:00. Seminar Room
Hosted by Prof. Turgut Durduran
In this presentation, clinical and preclinical research tools and approaches to test the capabilities of diffuse optics in early prediction of therapeutic efficacy will be introduced. For bone graft monitoring, temporal and spatial blood flow distributions from murine segmental defect model will be presented for different graft types with varying healing capacity: autografts, allografts, and allografts with tissue-engineered periosteum. For breast cancer monitoring, high correlation between temporal blood flow changes and the treatment efficacy assessed by tumor size changes in a murine breast cancer model will be shown. In addition, the potential of a multi-parametric approach based on clinical diffuse optical measurements to predict neoadjuvant chemotherapy efficacy will be demonstrated.
Diffuse optical and correlation tomography have a great potential to monitor and predict the efficacy of treatments that affect vascular parameters, since they provide non-invasive measurements of oxygenated and deoxygenated hemoglobin, and blood flow. In addition, the use of non-ionizing radiation and technologically simple, fast, inexpensive instrumentation makes diffuse optics attractive for translational research.
In this presentation, clinical and preclinical research tools and approaches to test the capabilities of diffuse optics in early prediction of therapeutic efficacy will be introduced. For bone graft monitoring, temporal and spatial blood flow distributions from murine segmental defect model will be presented for different graft types with varying healing capacity: autografts, allografts, and allografts with tissue-engineered periosteum. For breast cancer monitoring, high correlation between temporal blood flow changes and the treatment efficacy assessed by tumor size changes in a murine breast cancer model will be shown. In addition, the potential of a multi-parametric approach based on clinical diffuse optical measurements to predict neoadjuvant chemotherapy efficacy will be demonstrated.
Tuesday, July 12, 2016, 12:00. Seminar Room
Hosted by Prof. Turgut Durduran
All Insight Seminars
Light Seminars
October 19, 2016
L4H Seminar ANDREW M. LEIFER 'Imaging Whole-Brain Neural activity in a Moving Anima'
Light Seminars
July 20, 2016
L4H Seminar JONATHAN FISHER 'A Hitchhikers Guide to The Brain'
Light Seminars
July 13, 2016
L4H Seminar GUILLERMO AGUILAR 'From Laser Dermatology to a Window to the Brain for Chronic Access to Neural Tissues for Laser-based Diagnostics & Therapeutics'
Light Seminars
June 15, 2016
L4H Seminar PETER KNER 'Wavefront Correction for Superresolution Microscopy'
Light Seminars
May 11, 2016
L4H Seminar HAKHO LEE 'Exosomes as a Courier of Cancer Information'
Light Seminars
April 13, 2016
L4H Seminar ORIOL GALLEGO 'A New Approach to Determine the 3D Architecture of Protein Complexes Using Live-Cell Imaging'
Light Seminars
March 16, 2016
L4H Seminar STEPHEN WEBB 'Towards Extended 3D Super-Resolution Imaging: Adaptive Optics and Multifocal Imaging'
Light Seminars
March 1, 2016
L4H Seminar ULAS SUNAR 'Optical Imaging Guided Light Therapy Optimization'
Light Seminars
January 20, 2016
L4H Seminar SERGI PADILLA 'Combining Light Microscopy with Single Cell Transcriptomics to Pinpoint the Host-Cellular Factors Implicated in HIV-1 Entry'